| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 11050 | 2021 |
| Thyroid hormones and cancer: a comprehensive review of preclinical and clinical studies E Krashin, A Piekiełko-Witkowska, M Ellis, O Ashur-Fabian Frontiers in endocrinology 10, 59, 2019 | 201 | 2019 |
| Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation O Ashur-Fabian, A Avivi, L Trakhtenbrot, K Adamsky, M Cohen, ... Proceedings of the National Academy of Sciences 101 (33), 12236-12241, 2004 | 140 | 2004 |
| Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53 O Weizer‐Stern, K Adamsky, O Margalit, O Ashur‐Fabian, D Givol, ... British journal of haematology 138 (2), 253-262, 2007 | 119 | 2007 |
| Cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac PJ Davis, GV Glinsky, HY Lin, JT Leith, A Hercbergs, HY Tang, ... Frontiers in Endocrinology 5, 240, 2015 | 116 | 2015 |
| Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology AH Hercbergs, O Ashur-Fabian, D Garfield Current Opinion in Endocrinology, Diabetes and Obesity 17 (5), 432-436, 2010 | 108 | 2010 |
| The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide O Ashur-Fabian, Y Segal-Ruder, E Skutelsky, DE Brenneman, ... Peptides 24 (9), 1413-1423, 2003 | 102 | 2003 |
| Medically induced euthyroid hypothyroxinemia may extend survival in compassionate need cancer patients: an observational study A Hercbergs, RE Johnson, O Ashur-Fabian, DH Garfield, PJ Davis The oncologist 20 (1), 72-76, 2015 | 98 | 2015 |
| Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides O Ashur-Fabian, E Giladi, DE Brenneman, I Gozes Journal of Molecular Neuroscience 9, 211-222, 1997 | 94 | 1997 |
| The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation E Shinderman-Maman, K Cohen, C Weingarten, D Nabriski, O Twito, ... Oncogene 35 (15), 1977-1987, 2016 | 91 | 2016 |
| Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design I Gozes, O Perl, E Giladi, A Davidson, O Ashur-Fabian, S Rubinraut, ... Proceedings of the National Academy of Sciences 96 (7), 4143-4148, 1999 | 81 | 1999 |
| Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells K Cohen, N Flint, S Shalev, D Erez, T Baharal, PJ Davis, A Hercbergs, ... Oncotarget 5 (15), 6312, 2014 | 78 | 2014 |
| Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin K Cohen, M Ellis, S Khoury, PJ Davis, A Hercbergs, O Ashur-Fabian Molecular Cancer Research 9 (10), 1385-1394, 2011 | 75 | 2011 |
| NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis J Busciglio, A Pelsman, P Helguera, O Ashur-Fabian, A Pinhasov, ... Current pharmaceutical design 13 (11), 1091-1098, 2007 | 68 | 2007 |
| P53 in blind subterranean mole rats–loss-of-function versus gain-of-function activities on newly cloned Spalax target genes A Avivi, O Ashur-Fabian, A Joel, L Trakhtenbrot, K Adamsky, I Goldstein, ... Oncogene 26 (17), 2507-2512, 2007 | 62 | 2007 |
| Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis PJ Davis, HY Lin, T Sudha, M Yalcin, HY Tang, A Hercbergs, JT Leith, ... OncoTargets and therapy, 1619-1624, 2014 | 54 | 2014 |
| Contributions of thyroid hormone to cancer metastasis SA Mousa, GV Glinsky, HY Lin, O Ashur-Fabian, A Hercbergs, KA Keating, ... Biomedicines 6 (3), 89, 2018 | 53 | 2018 |
| apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53 O Ashur-Fabian, A Har-Zahav, A Shaish, H Wiener Amram, O Margalit, ... Cell Cycle 9 (18), 3785-3794, 2010 | 50 | 2010 |
| High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations A Vivante, N Amariglio, M Koren-Michowitz, O Ashur-Fabian, A Nagler, ... Leukemia 21 (6), 1318-1321, 2007 | 50 | 2007 |
| Long-term response in high-grade optic glioma treated with medically induced hypothyroidism and carboplatin: a case report and review of the literature O Ashur-Fabian, DT Blumenthal, M Bakon, D Nass, PJ Davis, ... Anti-cancer drugs 24 (3), 315-323, 2013 | 47 | 2013 |
